How does buagafuran interact with voriconazole in healthy adults?
This trial studies how a new drug, buagafuran, interacts with voriconazole (an antifungal medication). Healthy volunteers take both drugs to see if one affects the levels of the other in the body. The goal is to make sure the combination is safe and to understand dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are generally healthy with no major medical conditions
- Your body mass index (BMI) is between 19 and 28
- You are not pregnant, breastfeeding, or planning to have children during the study (and for 6 months after)
- You have not used any prescription or over-the-counter drugs, herbs, or supplements in the last 14 days
- You do not smoke heavily (more than 5 cigarettes a day)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes the study drug Buagafuran in people with mild to moderate liver impairment compared to those with healthy livers. It aims to understand dosing and safety for patients with liver disease.
This study tests how a new drug called TQB3616 interacts with other medicines. It is for healthy volunteers aged 18 to 45 to help understand how the drug is processed in the body.
This early-stage study tests how a common antifungal medication (itraconazole) changes how your body processes a new experimental drug called HS-10506. Researchers enroll healthy volunteers to understand safe dosing before testing in patients with real medical conditions.
This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.
This study checks if taking itraconazole, an antifungal medicine, changes how the body processes the investigational drug HS-10504. It helps researchers understand safe dosing and potential side effects.
This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.
Hear when a new Drug Drug Interaction (DDI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.